Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| -Change in Inventory | -$20.22M | $2.89M | -$13.10M | -$14.51M | -$6.02M |
| -Change in Payables and Accrued Expense | $23.58M | -$16.12M | -$8.27M | $46.96M | -$32.53M |
| -Change in Receivables | -$6.61M | -$6.68M | -$29.82M | $1.60M | $50.91M |
| Change in Working Capital | -$6.69M | -$24.13M | -$50.29M | $30.83M | $10.49M |
| Other Non-Cash Items | $9.96M | $10.75M | $5.92M | $9.39M | $1.44M |
| Deferred Tax | $19.32M | $17.89M | $23.45M | $12.77M | $13.08M |
| Depreciation & Depletion & Amortization | $38.51M | $38.32M | $40.50M | $31.37M | $25.22M |
| Gain/Loss from Continuing Operations | -$14.61M | -$48.35M | $22.13M | -$16.16M | -$38.64M |
| Net Income from Continuing Operations | $90.75M | $109.31M | $78.74M | $36.51M | $71.03M |
| Net cash flow from continuing operations | $137.86M | $92.76M | $129.13M | $110.31M | $90.26M |
| Operating Cash Flow | $137.86M | $92.76M | $129.13M | $110.31M | $90.26M |
| Free Cash Flow | $51.83M | $31.94M | $54.13M | $33.69M | $18.98M |
| -Change in Other Current Assets | -$3.43M | -$4.21M | $910,000.00 | -$3.22M | -$1.86M |
| Net cash flow from investing | -$85.04M | -$60.12M | -$73.22M | -$75.84M | -$70.51M |
| Net Cash Flow from Continuing Investing Activities | -$85.04M | -$60.12M | -$73.22M | -$75.84M | -$70.51M |
| Effect of Exchange Rate Changes | $3.39M | -$4.33M | $1.61M | -$5.72M | $1.56M |
| Beginning Cash Balance | $91.21M | $105.44M | $66.26M | $68.30M | $80.57M |
| Net Change in Cash | $7.15M | -$9.91M | $37.57M | $3.67M | -$13.83M |
| Ending Cash Balance | $101.74M | $91.21M | $105.44M | $66.26M | $68.30M |
| Net Other Financing Charges | -$3.39M | -$2.97M | – | -$1.76M | -$2.78M |
| Proceeds from Stock Option Exercised | $324,000.00 | $1.14M | $4.38M | $2.39M | $277,000.00 |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Issuance Payments Of Debt | -$38.26M | -$23.88M | -$16.36M | -$14.07M | -$26.64M |
| Net Cash Flow from Continuing Financing Activities | -$45.67M | -$42.55M | -$18.34M | -$30.81M | -$33.58M |
| Financing Cash Flow | -$45.67M | -$42.55M | -$18.34M | -$30.81M | -$33.58M |
| Net PPE Purchase and Sale | -$86.03M | -$60.81M | -$74.99M | -$76.63M | -$71.28M |
| Net Investment Purchase and Sale | – | – | $1.78M | $790,000.00 | – |
No comments yet — be the first to weigh in on ERO.